Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venetoclax salvage therapy in relapsed/refractory multiple myeloma.
Steinhardt MJ, Truger M, Bittrich M, Zhou X, Noderer J, Riedhammer C, Xiao X, Gawlas S, Weis P, Eisele F, Haferlach C, Mersi J, Waldschmidt J, Einsele H, Rasche L, Kortüm KM. Steinhardt MJ, et al. Among authors: riedhammer c. Haematologica. 2024 Mar 1;109(3):979-981. doi: 10.3324/haematol.2023.283472. Haematologica. 2024. PMID: 37794827 Free PMC article. No abstract available.
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.
Riedhammer C, Düll J, Kestler C, Kadel S, Franz J, Weis P, Eisele F, Zhou X, Steinhardt M, Scheller L, Mersi J, Waldschmidt JM, Einsele H, Turnwald D, Kortüm KM, Surat G, Rasche L. Riedhammer C, et al. Ann Hematol. 2024 Apr;103(4):1327-1332. doi: 10.1007/s00277-023-05586-8. Epub 2023 Dec 20. Ann Hematol. 2024. PMID: 38123879 Free PMC article.
Real-world analysis of teclistamab in 123 RRMM patients from Germany.
Riedhammer C, Bassermann F, Besemer B, Bewarder M, Brunner F, Carpinteiro A, Einsele H, Faltin J, Frenking J, Gezer D, Goldman-Mazur S, Hänel M, Hoegner M, Kortuem KM, Krönke J, Kull M, Leitner T, Mann C, Mecklenbrauck R, Merz M, Morgner A, Nogai A, Raab MS, Teipel R, Wäsch R, Rasche L. Riedhammer C, et al. Leukemia. 2024 Feb;38(2):365-371. doi: 10.1038/s41375-024-02154-5. Epub 2024 Jan 20. Leukemia. 2024. PMID: 38245601 Free PMC article.
Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.
Zhou X, Wagner V, Scheller L, Stanojkovska E, Riedhammer C, Xiao X, Steinhardt MJ, Vogt C, Nerreter S, Eisele F, John M, Munawar U, Kadel SK, Mersi J, Ruckdeschel A, Schimanski S, Haertle L, Waldschmidt JM, Han S, Topp M, Duell J, Einsele H, Riedel A, Kortüm KM, Rasche L. Zhou X, et al. Among authors: riedhammer c. Br J Haematol. 2024 May 8. doi: 10.1111/bjh.19515. Online ahead of print. Br J Haematol. 2024. PMID: 38719214
Effects of Alemtuzumab on (Auto)antigen-Specific Immune Responses.
Hilger C, Riedhammer C, Orsó E, Weissert R. Hilger C, et al. Among authors: riedhammer c. Front Immunol. 2020 Oct 8;11:563645. doi: 10.3389/fimmu.2020.563645. eCollection 2020. Front Immunol. 2020. PMID: 33133074 Free PMC article.
IL-3 promotes the development of experimental autoimmune encephalitis.
Renner K, Hellerbrand S, Hermann F, Riedhammer C, Talke Y, Schiechl G, Rodriguez Gomez M, Kutzi S, Halbritter D, Goebel N, Brühl H, Weissert R, Mack M. Renner K, et al. Among authors: riedhammer c. JCI Insight. 2016 Oct 6;1(16):e87157. doi: 10.1172/jci.insight.87157. JCI Insight. 2016. PMID: 27734026 Free PMC article.
11 results